Search clinical trials for: XEN45 (Glaucoma Gel Stent)

Total 29 results

AbbVie

Recruiting

Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma

Open-Angle Glaucoma

United States, Australia
Trakya University

Completed

An Innovation in Glaucoma Surgery: XEN45 Gel Stent Implantation

Glaucoma Eye
AqueSys, Inc.

Completed

Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants

Primary Open Angle Glaucoma

Spain, Austria, Belgium, Italy, Germany, Poland, Switzerland, United Kingdom, Venezuela
AbbVie

Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China

Open-angle Glaucoma | OAG

China
Zhongshan Ophthalmic Center, Sun Yat-sen University
Allergan

Active, not recruiting

XEN45 in the Treatment of Chinese Patients With Primary Open-angle Glaucoma

Glaucoma | Glaucoma, Open-Angle | Surgery

China
Hospital Clinic of Barcelona

Completed

Analysis of Conjunctival Changes as Indicators for Ab-interno Gelatin Microstent Implantation Surgery Outcomes (IIT_XEN)

Glaucoma | Glaucoma Open-Angle Primary

Spain
Allergan

Completed

Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma

Refractory Glaucoma

China
Glaukos Corporation

Completed

Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract

Open-angle Glaucoma
Swiss Vision Network

Active, not recruiting

Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent

Glaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Primary Open Angle
Johns Hopkins University
New York University

Completed

Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach

Glaucoma, Open-Angle

United States
Cairo University

Recruiting

Effect of Nano-Bio Fusion Gel on Palatal Wound Healing After Free Gingival Graft Harvest.

Free Gingival Graft

Egypt
Allergan

Completed

XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) (XEN GPS)

Glaucoma

United States
Glaukos Corporation

Completed

A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.

Open-Angle Glaucoma

Germany, Spain, Turkey, Netherlands, Austria
Abbott Medical Devices

Completed

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) (PROTECT)

Carotid Artery Disease

United States
Tanta University

Recruiting

Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis (RCT)

Oral Ulcer

Egypt
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease (LEFT-MAIN-2)

Coronary Disease

Germany, Italy
North Texas Veterans Healthcare System

Completed

AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study (ACE-CTO)

Coronary Occlusions

United States
Spanish Society of Cardiology

Completed

A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study

Myocardial Infarction

Spain, Italy, Netherlands
Abbott Medical Devices

Terminated

ABSORB PHYSIOLOGY Clinical Investigation

Coronary Artery Disease

Netherlands, Australia, Singapore, China
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (DES-ISR)

In-stent Restenosis

Korea, Republic of
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Limin Feng

Recruiting

Efficacy of Estrogen-intrauterine Stent System After Intrauterine Adhesiolysis

Intrauterine Adhesion

China
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS V)

In-Stent Restenosis

Spain
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS IV)

In-stent Restenosis

Spain
Seoul National University Hospital
Boston Scientific Corporation; Abbott

Unknown

Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing (EXCELLENT)

Coronary Artery Disease

Korea, Republic of
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

Hepatitis C

United States, Australia, New Zealand, Puerto Rico
Mohit Khera

Terminated

Testosterone for Penile Rehabilitation After Radical Prostatectomy

Erectile Dysfunction | Hypogonadism

United States
Retina Vitreous Associates of Florida

Completed

Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival

Age-related Macular Degeneration | Central Retinal Vein Occlusion | Diabetic Macular Edema

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous Adenocarcinoma

United States, United Kingdom

Search clinical trials for: XEN45 (Glaucoma Gel Stent)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations